Rosalind Advisors, Inc.

TORONTO, A6 · CIK 1622627 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Legal entityRosalind Advisors, Inc. (CA)

$266.2m reported value +9.1% vs Q1 2026

29positions

74.9%in top 10

3 new 7 added 11 reduced 6 sold out vs Q1 2026

Options: 2 call positions ($505.9k notional), 4 put positions ($2.5m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	DELCATH SYS INC COM NEW DCTH	DCTH	3,300,389	$41.6m15.61%	15.61%	Unchanged
2	FENNEC PHARMACEUTICALS INC COM FENC	FENC	3,188,001	$34.3m12.87%	12.87%	Added +279.8k	+279,800 9.6%
3	XERIS BIOPHARMA HOLDINGS INC COM XERS	XERS	2,908,981	$23.0m8.65%	8.65%	Reduced -322.7k	-322,719 -10.0%
4	SAVARA INC COM SVRA	SVRA	3,178,121	$19.6m7.35%	7.35%	Reduced -25.6k	-25,600 -0.8%
5	VERASTEM INC COM NEW VSTM	VSTM	3,986,509	$15.2m5.72%	5.72%	Added +1.8m	+1,848,034 86.4%
6	X4 PHARMACEUTICALS INC COM NEW XFOR	XFOR	3,214,766	$15.0m5.64%	5.64%	Unchanged
7	EYEPOINT PHARMACEUTICALS INC COM NEW EYPT	EYPT	988,230	$14.1m5.31%	5.31%	Reduced -48.5k	-48,507 -4.7%
8	CYBIN INC COM NEW COM NEW		1,956,814	$12.9m4.86%	4.86%	Added +425.0k	+425,000 27.7%
9	VOR BIOPHARMA INC COM NEW VOR	VOR	648,600	$11.9m4.49%	4.49%	Reduced -51.4k	-51,400 -7.3%
10	VAXCYTE INC COM PCVX	PCVX	200,000	$11.6m4.37%	4.37%	Reduced -90.0k	-90,000 -31.0%
11	MEDIWOUND LTD SHS NEW MDWD	MDWD	749,054	$11.0m4.14%	4.14%	Unchanged
12	CELLDEX THERAPEUTICS INC NEW COM NEW CLDX	CLDX	200,000	$7.4m2.80%	2.80%	Reduced -130.0k	-130,000 -39.4%
13	BIOCRYST PHARMACEUTICALS INC COM BCRX	BCRX	721,504	$7.2m2.71%	2.71%	Reduced -201.6k	-201,553 -21.8%
14	PROFOUND MED CORP COM NEW PROF	PROF	828,118	$5.5m2.07%	2.07%	Unchanged
15	TALPHERA INC COM NEW TLPH	TLPH	5,169,501	$5.3m2.00%	2.00%	Added +1.8m	+1,815,585 54.1%
16	ATEA PHARMACEUTICALS INC COM AVIR	AVIR	1,070,550	$5.0m1.87%	1.87%	Reduced -101.3k	-101,305 -8.6%
17	MYOMO INC COM NEW MYO	MYO	3,637,886	$3.8m1.42%	1.42%	Reduced -209.4k	-209,386 -5.4%
18	OVID THERAPEUTICS INC COM OVID	OVID	1,107,994	$3.0m1.12%	1.12%	Unchanged
19	NEURAXIS INC COM NRXS	NRXS	508,055	$3.0m1.12%	1.12%	Added +221.9k	+221,917 77.6%
20	ABIVAX SA SPONSORED ADS ABVX	ABVX	20,869	$2.8m1.04%	1.04%	New
21	INSPIREMD INC COM NSPR	NSPR	3,905,743	$2.7m1.03%	1.03%	Unchanged
22	REGENTIS BIOMATERIALS LTD ORDINARY SHARES RGNT	RGNT	701,685	$2.5m0.93%	0.93%	Added +450.2k	+450,175 179.0%
23	POLYPID LTD COM PYPD	PYPD	389,455	$2.0m0.74%	0.74%	Reduced -208.5k	-208,471 -34.9%
24	BIOFRONTERA INC COM NEW BFRI	BFRI	1,275,609	$1.2m0.45%	0.45%	Added +111.6k	+111,647 9.6%
25	KURA ONCOLOGY INC COM KURA	KURA	100,000	$1.1m0.41%	0.41%	Unchanged
26	SPRUCE BIOSCIENCES INC COM NEW SPRB	SPRB	20,000	$1.1m0.41%	0.41%	New
27	AQUESTIVE THERAPEUTICS INC COM AQST	AQST	250,000	$1.0m0.39%	0.39%	Unchanged
28	ONKURE THERAPEUTICS INC COM CL A OKUR	OKUR	150,000	$684.0k0.26%	0.26%	Reduced -293.8k	-293,763 -66.2%
29	PEPGEN INC COM PEPG	PEPG	350,000	$630.0k0.24%	0.24%	New

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
CG ONCOLOGY INC CGON	CGON	100,000	$6.8m100.0k shares
VIRIDIAN THERAPEUTICS INC VRDN	VRDN	250,401	$4.9m250.4k shares
DEFINIUM THERAPEUTICS INC DFTX	DFTX	125,000	$2.4m125.0k shares
LIPOCINE INC NEW LPCN	LPCN	221,616	$1.8m221.6k shares
AVALO THERAPEUTICS INC AVTX	AVTX	75,000	$1.1m75.0k shares
ANNEXON INC ANNX	ANNX	200,000	$1.1m200.0k shares

Options (notional value)

Underlying	Ticker	Type	Shares controlled	Notional	Change
SELLAS LIFE SCIENCES GROUP I SLS · Put	SLS	Put	568,700	$2.3m568.7k shares	New
CG ONCOLOGY INC CGON · Call	CGON	Call	31,000	$375.1k31.0k shares	New
EYEPOINT PHARMACEUTICALS INC EYPT · Call	EYPT	Call	50,300	$130.8k50.3k shares	New
ISHARES TR Put		Put	500,000	$110.0k500.0k shares	New
SPDR SER TR Put		Put	140,600	$35.1k140.6k shares	New
TENAX THERAPEUTICS INC TENX · Put	TENX	Put	6,200	$13.9k6.2k shares	New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
DELCATH SYS INC DCTH · 13D · filed 2026-10-19	DCTH	9.9%≈ $47.6m	no change	13D	2026-10-19
FEMASYS INC FEMY · 13G · filed 2026-08-14	FEMY	9.9%≈ $3.8m	new	13G	2026-08-14
REGENTIS BIOMATERIALS LTD RGNT · 13G · filed 2026-08-13	RGNT	9.9%	new	13G	2026-08-13
TALPHERA INC TLPH · 13G · filed 2026-08-12	TLPH	9.9%≈ $5.8m	no change	13G	2026-08-12
BIOFRONTERA INC BFRI · 13G · filed 2026-08-12	BFRI	9.9%≈ $15.9m	no change	13G	2026-08-12
MYOMO INC MYO · 13G · filed 2026-08-12	MYO	9.9%≈ $4.5m	no change	13G	2026-08-12
POLYPID LTD PYPD · 13G · filed 2026-08-12	PYPD	9.9%≈ $26.0m	no change	13G	2026-08-12
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-02-11	KPRX	9.9%	no change	13G	2026-02-11
FENNEC PHARMACEUTICALS INC FENC · 13G · filed 2026-08-13	FENC	9.6%≈ $35.7m	+0.8 pts	13G	2026-08-13
INSPIREMD INC NSPR · 13G · filed 2026-02-11	NSPR	9.2%≈ $7.7m	-0.7 pts	13G	2026-02-11
MEDIWOUND LTD 13G · filed 2026-02-11		7.0%	no change	13G	2026-02-11
CELLECTAR BIOSCIENCES INC 13G · filed 2026-02-10		5.5%	-4.4 pts	13G	2026-02-10